Profile data is unavailable for this security.
About the company
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
- Revenue in USD (TTM)195.65m
- Net income in USD28.79m
- Incorporated2020
- Employees217.00
- LocationBiote Corp1875 W. Walnut Hill Ln #100, Floor 5IRVING 75038United StatesUSA
- Phone+1 (972) 486-9346
- Fax+1 (916) 443-1908
- Websitehttps://haymakeracquisition.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jinxin Technology Holding Co (ADR) | -100.00bn | -100.00bn | 30.70m | 103.00 | -- | 1.77 | -- | -- | -- | -- | -- | 0.2535 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.62 | -- | 0.00 | -- | 7.00 | -- | -71.25 | -- | -- | -- |
| Postmedia Network Canada Corp | 316.61m | -53.48m | 68.80m | 1.51k | -- | -- | -- | 0.2173 | -0.7386 | -0.7386 | 4.37 | -4.23 | 3.00 | 118.89 | 6.89 | -- | -50.59 | -23.16 | -190.00 | -39.11 | 52.37 | 55.44 | -16.89 | -11.05 | 0.8047 | 0.2227 | 212.08 | -- | 8.98 | -3.23 | -55.56 | -- | -3.38 | -- |
| Chegg Inc | 376.91m | -103.42m | 71.11m | 1.24k | -- | 0.5944 | -- | 0.1887 | -0.9609 | -0.9609 | 3.51 | 1.08 | 0.6579 | -- | 19.21 | -- | -18.05 | -7.11 | -43.30 | -8.40 | 60.19 | 69.09 | -27.44 | -20.19 | -- | -99.94 | 0.3101 | -- | -38.97 | -10.17 | 87.64 | -- | -27.45 | -- |
| biote Corp | 195.65m | 28.79m | 96.35m | 217.00 | 2.46 | -- | 2.67 | 0.4925 | 0.8582 | 0.8582 | 5.70 | -2.37 | 1.84 | 3.33 | 23.76 | 901,589.90 | 30.54 | -- | 65.61 | -- | 72.23 | 67.10 | 16.59 | 7.51 | 0.7224 | 3.74 | 1.84 | -- | 6.38 | 12.39 | -4.79 | -31.73 | 32.99 | -- |
| Goodheart-Willcox Company Inc | -100.00bn | -100.00bn | 195.30m | 56.00 | -- | 6.77 | -- | -- | -- | -- | -- | 61.89 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | 21.66 | -- | 78.03 | -- | -- | -- |
| Lee Enterprises Inc | 547.84m | -26.46m | 198.82m | 2.50k | -- | -- | -- | 0.3629 | -4.35 | -4.35 | 89.82 | -7.81 | 0.894 | 2.23 | 9.90 | 219,136.80 | -4.02 | -1.01 | -4.98 | -1.22 | 97.75 | 96.66 | -4.50 | -1.08 | 0.6953 | 0.7011 | 1.11 | -- | -8.02 | -1.87 | -45.46 | -- | -28.22 | -- |
| Value Line Inc | 34.52m | 21.26m | 340.29m | 117.00 | 16.05 | 3.23 | 15.07 | 9.86 | 2.26 | 2.26 | 3.67 | 11.22 | 0.2398 | -- | 28.53 | 295,008.60 | 14.76 | 16.28 | 17.34 | 20.10 | 82.32 | 85.97 | 61.58 | 54.29 | -- | -- | 0.00 | 46.58 | -6.42 | -2.74 | 8.78 | 6.72 | 159.86 | 8.45 |
| Holder | Shares | % Held |
|---|---|---|
| Roystone Capital Management LPas of 05 Jun 2025 | 4.62m | 14.33% |
| 325 Capital LLCas of 31 Dec 2025 | 4.55m | 14.10% |
| Bandera Partners LLCas of 31 Dec 2025 | 2.28m | 7.08% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 1.62m | 5.01% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.28m | 3.97% |
| Acadian Asset Management LLCas of 31 Dec 2025 | 620.79k | 1.92% |
| Geode Capital Management LLCas of 31 Dec 2025 | 620.26k | 1.92% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 600.11k | 1.86% |
| Dimensional Fund Advisors LPas of 31 Dec 2025 | 538.49k | 1.67% |
| GlobeFlex Capital LPas of 31 Dec 2025 | 272.40k | 0.84% |
